Interaction of mucosal microbiota with the innate immune system

Scandinavian Journal of Immunology, Supplement

Volumn 62, Issue 1, 2005, Pages 106-113

  Tlaskalova Hogenova, H ^a   Tuckova, L ^a   Mestecky, J ^b   Kolinska, J ^c   Rossmann, P ^a   Stepankova, R ^a   Kozakova, H ^a   Hudcovic, T ^a   Hrncir, T ^a   Frolova, L ^a   Kverka, M ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b University of Alabama at Birmingham   (United States)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD11B ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD1D ANTIGEN; CD32 ANTIGEN; CD40 ANTIGEN; CD64 ANTIGEN; CHEMOKINE; COMPLEMENT; CYTOKINE; GANGLIOSIDE GM1; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA E ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TOLL LIKE RECEPTOR; UNINDEXED DRUG; UVOMORULIN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BACTEROIDES; BIFIDOBACTERIUM; CELL DIVISION; CELL INTERACTION; CELL MIGRATION; CELL TRANSPORT; CLOSTRIDIUM; COMMENSALISM; CYTOKINE PRODUCTION; DENDRITIC CELL; EPITHELIUM CELL; EUBACTERIUM; EXTRACELLULAR MATRIX; FUSOBACTERIUM; HELICOBACTER PYLORI; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; LEUKOCYTE; MACROPHAGE; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

EID: 23744456226     PISSN: 03016323     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01618.x     Document Type: Review

References (60)

1. Mestecky J, Rüssel MW, Jackson S, Michalak SM, Tlaskalova-Hogenova H, Sterzl J, eds. Advances in Mucosal Immunology. New York/London: Plenum Press, 1995.
2. Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee J, eds. Mucosal Immunology. New York: Academic Press, 1999.
3. Tlaskalova H, Tuckova L, Lodinova-Zadnikova R et al. Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol 2002;128:77-89.
4. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570-7.
5. Cummings JH, Antoine JM, Azpiroz F, et al. PASSCLAIM - gut health and immunity. Eur J Nutr 2004;43 (Suppl. 2):II118-II173.
6. Mestecky J, Blumberg RS, Kiyono H, McGhee JR. The mucosal immune system. In: Paul WE, ed. Fundamental Immunology. Philadelphia: Lippincott Williams & Wilkins, 2004: 965-1020.
7. Medzhitov R, Janeway CA Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000;173:89-97.
8. Akira S. Toll-like receptors and innate immunity. Adv Immunol 2001;78:1-56.
9. Bevins CK, Martin-Poter E, Ganz T. Defensins and innate host defence of the gastrointestinal tract. Gut 1999;45:911-5.
10. Ghosh D, Porter E, Shen BO et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002;3:583-9.
11. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269-73.
12. Fasano A. Intestinal zonulin: open sesame! Gut 2001;49:159-62.
13. Van Beers EH, Buller HA, Grand RJ, Einerhard AWC, Dekker J. Intestinal brush border glyco hydrolases. Critic Rev Biochem Mol Biol 1995;30:197-262.
14. Moon HW. Epithelial cell migration in alimentary mucosa of suckling pig. Proc Soc Exp Biol Med 1971;137:151-4.
15. Mandel L, Moravek F, Miler I. The re-epithelization of intestinal mucosa in gamma-irradiated, partially shielded gnotobiotic piglets. Strahlentherapie 1974;147:308-14.
16. Savage DC, Walker-Smith JA, Philips AD. Intestinal proliferation in coeliac disease: looking into the crypt. Gut 1995;36:321-3.
17. Meinzer HP, Sandblad B. Evidence for generation controlled proliferation in the small intestinal crypt. Cell Tissue Kinet 1986;9:581-90.
18. Loeffler M, Stein R, Wichmann H-E, Potten CS, Kaur P, Chwalinski S. Intestinal cell proliferation. I. A comprehensive model of steady-state proliferation in the crypt. Cell Tissue Kinet 1986;19:627-45.
19. Potten CS, Morris RJ. Epithelial stem cells in vivo. J Cell Sci Suppl 1988;10:45-62.
20. Lacroix B, Kedinger M, Simon-Assmann P, Haffen K. Early organogenesis of human small intestine: scanning electron microscopy and brush-border enzymology. Gut 1984;25:925-30.
21. Potten CS. Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res 2004;161:123-36.
22. Potten CS, Booth C, Tudor GL et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003;71:28-41.
23. Smith PS, Smythies LE, Mosteller-Barnum M et al. Intestinal macrophages lack CD 14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001;167:2651-6.
24. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
25. Bilsborough J, Viney JL. Gastrointestinal dendritic cells play a role in immunity, tolerance and disease. Gastroenterology 2004;127:300-9.
26. Granucci F, Zanoni I, Feau S, Capuano G, Ricciardi-Castagnoli P. The regulatory role of dendritic cells in the immune response. Int Arch Allergy Immunol 2004;134:179-85.
27. Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003;170:2274-8.
28. Cebra J, Jiang HQ, Sterzl J, Tlaskalova-Hogenova H. The role of mucosal microbiota in the development and maintenance of the mucosal immune system. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee J, eds. Mucosal Immunology. New York: Academic Press, 1999: 267-80.
29. Elson CO, Cong Y. Understanding immune-microbial homeostasis in intestine. Immunol Res 2002;26:87-94.
30. Cukrowska B, Lodinova-Zadnikova R, Enders C, Sonnenborn U, Schulze J, Tlaskalova-Hogenova H. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol 2002;55:204-9.
31. Lodinova-Zadnikova R, Cukrowska B, Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy 2003;131:209-11.
32. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;8:1831.
33. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 2004;93:97-108.
34. Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002;6:2982-90.
35. Wilson M, McNab R, Henderson B, eds. Bacterial Disease Mechanisms. Cambridge: Cambridge University Press, 2002.
36. Tlaskalova-Hogenova H. Gnotobiology as a tool - An introduction. In: Lefkovits I, ed. Immunology Methods Manual. London: Academic Press, 1997: 1524-9.
37. Hooper LV, Gordon JI. Commensal host-bacteria relationships in the gut. Science 2001;292:1115-8.
38. Gustafsson JA. Germfree rearing of rats. Acta Pathol Microbiol Scand 1948;22 (Suppl. 1):1-132.
39. Pleasants JR, Johnson MH, Wostman BS. Adequacy of chemically defined, water-soluble diet for germfree BALB/c mice through successive generations and litters. J Nutr 1986;116:1949-64.
40. Sterzl J, Mandel J, Stepankova R. The use of gnotobiological models for the studies of immune mechanisms. Nahrung 1987;31:599-608.
41. Tlaskalova-Hogenova H, Cerna J, Mandel L. Peroral immunization of germfree piglets: appearance of antibody-forming cells and antibodies of different isotypes. Scand J Immunol 1981;13:467-72.
42. Tlaskalova-Hogenova H, Sterzl J, Stepankova R et al. Development of immunological capacity under germfree and conventional conditions. Ann NY Acad Sci 1983;409:96-113.
43. Cukrowska B, Sinkora J, Rehakova Z et al. Isotype and antibody specificity of spontaneously formed immunoglobulins in pig fetuses and germ-free piglets: production by CD5-B cells. Immunology 1996;88:6ll-7.
44. Tlaskalova H, Kamarytova V, Mandel L et al. The immune response of germ-free piglets after peroral monocontamination with living Escherichia coli strain 086. I. The fate of antigen, dynamics and site of antibody formation, nature of antibodies and formation of heterohaemagglutinins. Folia Biol 1970;16:177-87.
45. Cukrowska B, Kozakova H, Rehakova Z, Sinkora J, Tlaskalova-Hogenova H. Specific antibody and immunoglobulin responses after intestinal colonization of germ-free piglets with non-pathogenic Escherichia coli 086. Immunobiology 2001;204:425-33.
46. Funda DP, Tuckova L, Farre MA, Iwase T, Moro I, Tlaskalova-Hogenova H. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: Lipopolysaccharide activation of epithelial cells revisited. Infect Immun 2001;69:3772-81.
47. Haller D, Jobin Ch. Interaction between resident luminal bacteria and the host: Can a healthy relationship turn sour? J Pediatr Gastroenterol Nutr 2004;38:123-36.
48. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bunsussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004;53:821-8.
49. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001;167:1609-16.
50. Neish AS, Gewirtz AT, Zeng H et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 2000;289:1483-4.
51. Kelly D, Campbell JI, King TP et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and ReIA. Nat Immunol 2004;5:104-12.
52. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004;5:800-8.
53. Vidal K, Donnet-Hughes A, Granato D. Lipoteichoic acid from Lactobacillus johmonii strain La1 and Lactobacillus acidophilus strain LaIO antagonize the responsiveness for human intestinal epithelial HT29 cells to lipopolysaccharide and gram-negative bacteria. Infect Immun 2002;70:2057-64.
54. Kobayashi K, Hernandez LD, Galan JE et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002;110:191-2.
55. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
56. Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
57. Hayashi H, Abdollah S, Qiu Y et al. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 1997;89:1165-73.
58. Elliot J, Johnston JA. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol 2004;25:434-40.
59. Greten FR, Eckmann L, Greten TF et al. IKK-β links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;18:285-96.
60. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.